β-blocker use in patients after percutaneous coronary interventions: One size fits all? Worse outcomes in patients without myocardial infarction or heart failure
Neiko Ozasa(Kyoto University), Takeshi Kimura(Municipal Hirakata City Hospital), Bingyuan Bao(Kyoto University), Junichi Tazaki(Hyogo Medical University), Yutaka Furukawa(Kobe City Medical Center General Hospital), Hiroki Shiomi(Kyoto University), Masashi Iwabuchi(Kindai University Hospital), Kazushige Kadota(Kurashiki Central Hospital), Yoshihisa Nakagawa(Shiga University of Medical Science), Takeshi Morimoto(Hyogo Medical University), Masahiro Natsuaki(Saga University), Satoshi Shizuta(Kyoto University)
Cited by 31
Related Papers
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582
Three-Year Follow-up after Implantation of Metallic Coronary-Artery Stents
|New England Journal of Medicine|1996|507
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease
|Circulation Journal|2020|363
Effect of Intensive Statin Therapy on Regression of Coronary Atherosclerosis in Patients With Acute Coronary Syndrome
|Journal of the American College of Cardiology|2009|359